Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcturus Therapeutics Holdings Inc ARCT

Healthcare Biotechnology
Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid... see more

Recent & Breaking News (NDAQ:ARCT)

Alcobra Announces Third Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire November 15, 2016

Alcobra Ltd. to Participate in Upcoming Healthcare Conferences

GlobeNewswire November 7, 2016

Alcobra Ltd. to Release Third Quarter Financial Results and Host Corporate Update Conference Call & Webcast on November 15

GlobeNewswire November 1, 2016

Update from Alcobra on Recent FDA Communications

GlobeNewswire October 7, 2016

12 Biggest Mid-Day Losers For Friday

Benzinga.com  September 30, 2016

The Market In 5 Minutes: Deutsche Bank Woes Bring Down Indexes

Benzinga.com  September 30, 2016

12 Biggest Mid-Day Losers For Thursday

Benzinga.com  September 29, 2016

Mid-Day Market Update: Crude Oil Rises Over 2%; Intra-Cellular Therapies Shares Slide

Benzinga.com  September 29, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  September 29, 2016

Mid-Morning Market Update: Markets Edge Lower; PepsiCo Beats Q3 Expectations

Benzinga.com  September 29, 2016

Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study

GlobeNewswire September 28, 2016

10 Biggest Mid-Day Losers For Tuesday

Benzinga.com  August 30, 2016

Alcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire August 30, 2016

Alcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30

GlobeNewswire August 15, 2016

Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome

GlobeNewswire July 19, 2016

Alcobra Ltd. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference

GlobeNewswire July 5, 2016

Alcobra Ltd. to Participate in Upcoming Investment Conferences

GlobeNewswire June 1, 2016

Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update

GlobeNewswire May 16, 2016

Alcobra Ltd. to Release First Quarter Financial Results and Host Corporate Update Conference Call & Webcast on May 16

GlobeNewswire May 4, 2016

Alcobra Ltd. to Present at Upcoming Investment Conferences

GlobeNewswire March 1, 2016